Research
LC-MS · HPLC

Metabolomics

Discovering nutritional biomarkers through metabolite profiling

Overview

Reading the Body's Chemical Language

Metabolomics is the comprehensive study of small-molecule metabolites — amino acids, lipids, organic acids, nucleotides — within a biological sample. These molecules are the downstream products of genomics, transcriptomics, and proteomics, and they reflect actual physiological state more directly than any upstream measurement.

Using LC-MS (Liquid Chromatography–Mass Spectrometry) and HPLC (High-Performance Liquid Chromatography), we profile serum and urine metabolomes in companion animals across a range of disease states, identifying biomarkers that can guide nutritional intervention and monitor treatment response.

⚗️

LC-MS/MS

High-sensitivity detection of low-abundance metabolites in complex matrices. Used for targeted amino acid panels, lipidomics, and bile acid profiling.

📊

HPLC (UV/FLD)

Quantitative analysis of water-soluble vitamins, organic acids, and urinary markers. High throughput for large-cohort clinical studies.

🧮

Multivariate Statistics

PCA, PLS-DA, and OPLS-DA to distinguish disease from healthy metabolomic signatures and identify the most discriminant biomarker candidates.

🗺️

Pathway Mapping

Integrating metabolite panels with KEGG and MetaboAnalyst pathway databases to understand which metabolic routes are disrupted in disease.

Disease-Specific Research Focus

Chronic Kidney Disease (CKD)

Key Markers

Uremic toxins (indoxyl sulfate, p-cresol sulfate), symmetric dimethylarginine (SDMA), creatinine-to-BUN ratio dynamics

Research Goal

Early detection biomarkers; monitoring phosphorus restriction efficacy

Hepatic Disease

Key Markers

Bile acids (primary/secondary), branched-chain amino acids (BCAA), ammonia metabolites, medium-chain acylcarnitines

Research Goal

Stratifying hepatic dysfunction severity and guiding protein source selection

Metabolic Syndrome & Obesity

Key Markers

Insulin resistance surrogates, adipokines, short-chain fatty acid precursors, triglyceride/HDL ratios

Research Goal

Identifying metabolically obese normal-weight (MONW) patients and customizing caloric restriction